Clinical Trial Information
A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis- Protocol Number: 9596
- Status: Open
- Treatment Type: Treatment
- Phase: III
- NCT ID: NCT02531126
Scope Information
- Disease Site(s):
- Other